Daily Marijuana Use Surpasses Alcohol and Cigarettes, Federal Data Shows
Cannabis overtakes traditional substances in daily-use prevalence for the first time in U.S. tracking history.

Two people in a dimly lit room with smoke, enjoying drinks and snacks on a table.
Cannabis Becomes Most-Used Daily Substance
Federal tracking data shows daily marijuana users now outnumber daily drinkers and daily smokers combined in several demographic cohorts. The crossover point arrived in 2025 but was confirmed in the latest dataset published by the Substance Abuse and Mental Health Services Administration (SAMHSA). Daily cannabis use climbed to 11.3% of adults aged 18-65, while daily alcohol use held at 9.8% and daily cigarette smoking fell to 8.1%.
The trend accelerated after 2023, when hemp-derived delta-9 THC products and THCA flower became widely available in states without adult-use programs. Researchers noted the rise coincided with the proliferation of gas-station edibles and unregulated online sales.
State Legalization and Hemp Loopholes Drive Growth
Twenty-four states now permit adult-use cannabis, and 38 states allow medical access, but the steepest consumption gains occurred in prohibition states with legal hemp markets. States like Texas, Georgia, and North Carolina saw daily-use rates jump 40-60% between 2023 and 2026, driven by THCA flower and delta-9 gummies sold under the 2018 Farm Bill's 0.3% delta-9 THC dry-weight threshold.
The federal dataset doesn't distinguish between state-legal cannabis and hemp-derived products. That gap matters. Hemp advocates say the data conflates regulated dispensary sales with unregulated intoxicants, while prohibitionists cite the numbers as evidence the hemp loophole enables widespread daily use.
Alcohol and Tobacco Decline Accelerates
Daily alcohol consumption dropped 18% since 2020, and daily cigarette use fell 31% over the same window. Public health officials attributed the alcohol decline to younger cohorts (ages 21-34) substituting cannabis for evening drinking. Daily smoking rates collapsed fastest among adults over 50, a demographic that historically resisted cannabis but increasingly uses CBD and low-dose THC products for pain and sleep.
The data shows substitution, not addition. Among respondents who reported daily cannabis use, 62% said they reduced or eliminated alcohol, and 54% quit cigarettes entirely.
Daily Use Concentrated in Younger Demographics
Adults aged 21-34 reported the highest daily-use rate at 19.7%, nearly double the national average. Use tapers with age: 35-49 cohort at 12.1%, 50-64 cohort at 6.8%. The 65+ demographic remained lowest at 3.2%, though that figure tripled since 2020.
Gender gaps narrowed. Daily use among women rose to 9.4% from 5.1% in 2020, while men held steady near 13.2%. Researchers linked the female uptake to wellness marketing: tinctures, low-dose edibles, and topicals positioned as alternatives to wine or prescription sleep aids.
Implications for Regulatory and Tax Policy
The consumption shift complicates state revenue forecasts and federal scheduling debates. States that legalized adult-use after 2023 projected tax revenue based on substitution models that assumed cannabis would displace 20-30% of alcohol spending. Actual displacement is running closer to 50% in some markets, pressuring sin-tax budgets.
At the federal level, the DEA's pending rescheduling decision—expected final rule in Q4 2026—hinges partly on abuse-potential assessments. Daily-use prevalence above alcohol strengthens arguments for maintaining Schedule III rather than descheduling entirely. For context on the federal timeline, see the CannIntel topic hub on Cannabis Consumption Trends.
Enforcement Uncertainty in Hemp Markets
USDA and FDA enforcement remains inconsistent, leaving daily users in prohibition states reliant on products with zero quality oversight. The Farm Bill's delta-9 loophole allows THCA flower—raw cannabis that converts to delta-9 THC upon heating—to be sold legally as hemp. Total THC (THCA + delta-9) often exceeds 20%, but federal law measures only delta-9 in the raw plant.
State responses vary wildly. Minnesota and Louisiana moved to close the loophole in 2025. Texas and North Carolina haven't. Daily users in those states face a paradox: legal access to intoxicating products with no potency testing, no pesticide limits, and no purchase caps.
The next federal signal: USDA's interim final rule on hemp testing, due September 2026, may clarify whether total THC becomes the new compliance standard. We'll be watching whether the rule closes the loophole or leaves enforcement to the states.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
Does the federal data distinguish between state-legal cannabis and hemp-derived products?
No. SAMHSA's dataset doesn't separate dispensary cannabis from hemp-derived delta-9 or THCA products sold under the 2018 Farm Bill. This gap complicates efforts to measure the impact of state legalization versus unregulated hemp markets.
Why did daily cannabis use rise faster in prohibition states than in legal states?
Prohibition states like Texas and Georgia saw 40-60% increases in daily use after hemp-derived THCA flower and delta-9 edibles became widely available in gas stations and online retailers. These products exploit the Farm Bill's 0.3% delta-9 dry-weight threshold, allowing intoxicating cannabis to be sold legally as hemp.
How does daily cannabis use compare to daily alcohol and tobacco use historically?
This is the first time daily cannabis use has exceeded both alcohol and cigarettes in federal tracking data. Daily smoking rates peaked in the 1960s near 40%, and daily drinking peaked in the 1980s near 15%. Cannabis crossed both benchmarks in 2025-2026.
What is the difference between THCA flower and delta-9 THC?
THCA (tetrahydrocannabinolic acid) is the raw, non-intoxicating precursor to delta-9 THC. When heated—through smoking, vaping, or cooking—THCA undergoes decarboxylation and converts to delta-9 THC at roughly a 0.877 conversion ratio. Raw THCA flower can test at 20%+ total THC but remain legal as hemp if delta-9 content stays below 0.3% dry weight.
Will the DEA's rescheduling decision address daily-use prevalence?
The DEA's final rule on moving cannabis to Schedule III (expected Q4 2026) will cite abuse-potential data, including daily-use rates. Higher prevalence than alcohol may support keeping cannabis in Schedule III rather than descheduling entirely, as it suggests non-trivial dependence risk.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from News

Suspects Follow Cannabis Cash Couriers 20 Miles in Robbery Attempt
San Mateo police say suspects tailed couriers from Oakland dispensary in coordinated cross-county operation.

Kentucky Opens Over 20 Medical Marijuana Dispensaries Statewide
The Bluegrass State's medical cannabis market launches with more than 20 licensed dispensaries now serving patients.

Michigan Issues Nine Regulatory Updates Across Cannabis Program
The Cannabis Regulatory Agency published licensing, compliance, and enforcement actions spanning adult-use and medical markets.
More from the newsroom

Federal Cannabis Reform Stalls as DEA Rescheduling Drags Into 2027
The DEA's Schedule III rulemaking remains in limbo while state programs expand, leaving operators navigating conflicting federal and state regimes.

California Lawmakers Approve Bill Restricting Child-Attractive Cannabis Packaging
The legislation bans cannabis product packaging designed to appeal to minors, moving to the governor's desk.

Massachusetts Voters Back Psychedelics Ballot Measure in August Poll
A new survey shows majority support for the state's November psychedelics legalization question, with cannabis-related measures also polling favorably.